药物缓释系统应用于玻璃体视网膜疾病的研究进展
摘要
玻璃体视网膜疾病如增殖性玻璃体视网膜增殖性疾病、视网膜色素变性、青光眼等是常见的致盲性慢性眼病,其治疗方法的研究一直是科学界的难点。利用药物缓释系统行眼内局部药物治疗是实现高效、持久、低毒药物治疗的有效手段。
出处
《中国眼耳鼻喉科杂志》
2009年第6期396-398,共3页
Chinese Journal of Ophthalmology and Otorhinolaryngology
基金
教育部新世纪优秀人才支持计划(NCET-05-0370)
参考文献20
-
1EBRAHIM S, PEYMAN G A, Lee P J. Applications of liposomes in ophthahnology [ J ]. Surv Ophthalmol, 2005, 50 ( 2 ) : 167-182.
-
2VELPANDIAN T, NARAYANAN K, NAG T C, et al. Retinal toxicity of intravitreally injected plain and liposome formulation of fluconazole in rabbit eye [ J ]. Indian J Ophthalmol, 2006, 54 (4) : 237 -240.
-
3SHINOHARA K, TANAKA M, SAKUMA T, et al. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy [ J]. Ophthalmic Surg Lasers Imaging, 2003, 34(4) :299-305.
-
4贡亦清,陈逖,石春和,殷孝健,周敏,陈永东.氟尿嘧啶脂质体玻璃体注射防治增生性玻璃体视网膜病变的实验研究[J].眼外伤职业眼病杂志,2008,30(2):90-92. 被引量:2
-
5BOURGES J L, GAUTIER S E, DELIE F, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles [ J ]. Invest Ophthalmol Vis Sci, 2003,44 ( 8 ) : 3562-3569.
-
6NKANSAH M, TZENG S Y, HOLDT A M, et al. Poly(lacticcoglycolic acid ) nanospheres and microspheres for short- and long- term delivery of bioactive ciliary neurotrophic factor [ J ]. Biotechnol Bioeng, 2008,100(5 ) : 1010-1019.
-
7ZHONG L, BRADLEY J, SCHUBERT W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice [ J ]. Invest Ophthalmol Vis Sci, 2007,48 ( 3 ) : 1212-1218.
-
8LIBBY R T, ANDERSON M G, PANG I H, et al. Inherited glaucoma in DBA/2J mice: Pertinent disease features for studying the neurodegeneration [ J ]. Vis Neurosci, 2005, 22 (5) : 637-648.
-
9WARD M S, KHOOBEHI A, LAVIK E B, et al. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres[ J]. J Phann Sci, 2007, 96 (3) :558-568.
-
10SAKAI T, KUNO N, TAKAMATSU F, et al. Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats[ J]. Invest Ophthalmol Vis Sci, 2007, 48(7) :3381-3387.
二级参考文献17
-
1梁厚成,惠延年.道诺霉素脂质体防治实验性增殖性玻璃体视网膜病变[J].中华眼底病杂志,1993,9(2):77-80. 被引量:8
-
2贡亦清,石春和,陈逖.氟尿嘧啶脂质体玻璃体内注射对兔视网膜毒性[J].眼外伤职业眼病杂志,2005,27(12):884-886. 被引量:1
-
3Rachal WF,Burton TC.Changing concepts of failures after retinal detachment surgery.Arch Ophthalmol,1979,97:480-483.
-
4Weller M,Wiedemann P,Heimann K.Proliferative vitreoretinopathy-is it anything more than wound healing at the wrong place? Int Ophthalmol,1990,14:105-117.
-
5Kon CH,Occleston NL,Aylward GW,et al.Expression of vitreous cytokines in proliferative vitreoretinopathy:a prospective study.Invest Ophthalmol Vis Sci,1999,40:705-712.
-
6Stern WH,Guerin CJ,Erickson PA,et al.Ocular toxicity of fluorouracil after vitrectomy.Am J Ophthalmol,1983,96:43-51.
-
7Blumenkranz M,Hernandez E,Ophir A,et al.5-fluorouracil:new applications in complicated retinal detachment for an established antimetabolite.Ophthalmology,1984,91:122-130.
-
8Stern WH,Lewis GP,Erickson PA,et al.Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.Am J Ophthalmol,1983,96:33-42.
-
9Hegazy HM,Peyman GA,Liang C,et al.Use of perfluorocarbon liquids,silicone oil,and 5-fluorouracil in the management of experimental PVR.Int Ophthalmol,1999,22:239-246.
-
10Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease [ J ]. Arch Ophthalmol, 1984, 102 (4) :598-604.
共引文献9
-
1刘丹岩,马景学.药物长效剂型防治增生性玻璃体视网膜病变[J].国际眼科纵览,2007,31(6):419-422.
-
2黄潇,魏锐利.眼用氟尿嘧啶的制备及体外评价[J].第二军医大学学报,2008,29(10):1227-1229. 被引量:5
-
3焦明菲,颜华.增生性玻璃体视网膜病变的药物治疗[J].眼科研究,2010,28(4):381-384. 被引量:7
-
4解孝锋,毕宏生,吴建峰,卢秀珍.汉防己甲素联合5-FU聚乳酸微球对兔PVR IL-1β和TNF-α表达的影响[J].国际眼科杂志,2010,10(7):1266-1268. 被引量:4
-
5王建欣,杨继章.玻璃体内注射型缓释微粒给药系统的研究进展[J].河北医科大学学报,2011,32(3):367-370.
-
6赵珍珍,于永斌,王雨晴.药物对增生性玻璃体视网膜病变影响的进展[J].哈尔滨医科大学学报,2011,45(6):610-612. 被引量:2
-
7赵春晖,王毓琴,程凌云.增生性玻璃体视网膜病变药物治疗新进展[J].中华眼科杂志,2013,49(8):752-757. 被引量:2
-
8杨晓旭,杨冬萍,俞洋.中医药防治增殖性玻璃体视网膜病变研究进展[J].辽宁中医药大学学报,2017,19(12):109-112. 被引量:4
-
9黄子韩,吴孟华,罗思敏,周宇,张英,马志国,曹晖.乳香的本草考证[J].中国中药杂志,2020,45(21):5296-5303. 被引量:16
-
1郑大凤,许玲,邓莹莹,汤咏梅.氟康唑联合那他霉素滴眼液治疗真菌性角膜溃疡[J].郧阳医学院学报,2008,27(3):259-260. 被引量:11
-
2李秋明,宋绣雯.维拉帕米对人巩膜成纤维细胞增殖和胶原合成的影响[J].河南医科大学学报,1996,31(3):42-44.
-
3李秋明,宋绣雯,尤毅,马志明.一种新增殖性玻璃体视网膜病变模型[J].河南医科大学学报,1993,28(3):232-233. 被引量:1
-
4胡建斌,樊映川,张国辉.增殖性玻璃体视网膜病变手术治疗的临床疗效分析[J].临床眼科杂志,1999,7(6):416-417.
-
5赵博军.血管内皮生长因子与增殖性玻璃体视网膜疾病[J].中国实用眼科杂志,1998,16(9):519-520. 被引量:1
-
6高方,王一,陈少军,刘勇.TNF-α、IGF、TGF-α在增殖性玻璃体视网膜疾病中的表达[J].第三军医大学学报,2004,26(5):429-431. 被引量:5
-
7吴元.加强对中间葡萄膜炎的认识,减少漏诊、误诊[J].中国社区医师,2012,28(23):6-6.
-
8李运平,包欣,谢田华,傅东红,史惠琴.曲安奈德玻璃体内注射联合氩激光治疗视网膜分支静脉阻塞黄斑水肿[J].临床眼科杂志,2010,18(6):552-554. 被引量:3
-
9汪浩.壳聚糖基生物医用材料研究新进展[J].云南中医中药杂志,2006,27(4):55-57. 被引量:5
-
10孙清磊,罗媛媛,宋颖,柳林.糖尿病性黄斑水肿的发病机制与治疗进展[J].中华老年多器官疾病杂志,2015,14(1):33-38. 被引量:21